Study on the Therapeutic Benefit on Lactoferrin in Patients with Colorectal Cancer Receiving Chemotherapy

Table 3

Comparison between parameters values of patients in test and control groups after 3 months (results represented as mean ± SD values).

Parameter	Control; mean ± SD	LF; mean ± SD
BUN (mg/dL)	17.8 ± 6.49	11.43 ± 3.7^*
Serum creatinine (mg/dL)	1.13 ± 0.398	0.851 ± 0.369
AST (IU/L)	32.94 ± 17.57	28.15 ± 11.83
ALT (IU/L)	29.22 ± 12.54	30.58 ± 18.32
Serum LF (ng/mL)	0.188 ± 0.035	0.282 ± 0.175
Serum GST enzyme (ng/mL)	0.72 ± 0.07	0.88 ± 0.08
INF-γ (pg/mL)	32.26 ± 4.81	33.96 ± 4.68^*
WBCs (*10^3 cell/µL )	7.41 ± 2.3	7.19 ± 1.65
Platelet (*10^3/mm^3)	191.8 ± 78.46	244.06 ± 74.87
CEA (ng/mL)	24.44 ± 26.56	16.75 ± 28.32
RBCs (*10^6/µL)	4.2 ± 0.46	4.9 ± 0.71
Neutrophil (%)	45.93 ± 5.1	57.33 ± 8.6
Hb (g/dL)	10.58 ± 1.6	13.06 ± 1.9

Note: ^*significant difference .